{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1oQ8hXxTMV\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/22135\/\">2002\u5e745\u67083\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/22135\/embed\/#?secret=1oQ8hXxTMV\" width=\"600\" height=\"338\" title=\"\u300a Animal Health News &#038; Notes for May 3, 2002 \u300b\u2014Brakke Consulting Website\" data-secret=\"1oQ8hXxTMV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 3, 2002 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** Company Earnings Releases &gt;&nbsp; Aventis reported that sales for the first quarter 2002 for animal health division Merial rose 4% to 458 million euros ($400 million).&nbsp; This figure includes Merial&rsquo;s poultry genetics business.&nbsp; (company website) &gt;&nbsp; Alpharma reported that sales of its animal health division in the first quarter 2002 were $70.5 million compared to $118 million in 2001.&nbsp; Operating income was $2.9 million in the first quarter compared to $34.7 million in 2001.&nbsp; The first quarter of 2001 included $34.5 million in revenue and $20.9 million of operating income related to last year&rsquo;s financial statement revision.&nbsp; As expected, first quarter revenues and operating income were negatively impacted by a change in business practices, the effect of which is substantially complete.&nbsp; Distributor inventory levels are approaching targeted levels.&nbsp; (company website) &gt;&nbsp; Virbac Corporation, the US division of Virbac S.A., reported record sales and operating income results for the first quarter ending March 31, 2002.&nbsp; Net sales for the first quarter 2002 rose 6% to a record $15.9 million from $15.0 million for the 2001 corresponding quarter.&nbsp; Excluding the effect of an accounting change, first quarter 2002 sales would have risen 20%. Strong sales for Virbac&rsquo;s veterinary products continued to drive growth.&nbsp; SalesView Full Post;"}